IPD

0.83%

6.0¢ impedimed limited

Ann: Appendix 4C & Quarterly Activities Report, page-86

First 86 Last

Share
Profile

Follow
Twodogs196

810 Posts.

343

24/06/22

11:19

Post #: 62182655
Share

Originally posted by Aqua65: ↑

There has been a lot of progress since then.

The company has plenty of funds.
About 3 years worth of funds at current cost/income level —however with increased uptake and income as private insurers ultimately pay for Sozo diagnostics for lymphodema monitoring & detection, the revenue should increase and then the company’s funds last ongoing through years.
By which time a lot more would be happening with renal disease (partnering with large company most likely ) and heart failure and sarcopenia as well.

ImpediMed is priced at an EV right now of barely $60 million, market cap $100 million aud.
With sufficient reserve funds for the next few years.

ImpediMed is income and revenue generating and without doubt not only important fully approved and providing the best simple & only medical diagnostics for fluid definition for detection of lymphedema—but also accurate diagnosis for renal disease status and heart failure and for chemotherapy patients to be accurately assessed prior to treatments.

You have the sad part right but there is nothing bad - it’s just slow & covid has been big factor for hospitals.

There is no reason private insurance payers will now not soon be forced to pay routinely for the diagnostics and end the need for every claim to be pursued for their payment as is currently occurring. Requiring administrative work to receive payment but the centres and hospitals which use Sozo are very happy and Sozo is crucial to diagnosis & care.

Hospital administrations will jump more once one private insurer begins to blanket pay for all.

The main and best cancer clinics everywhere already use Sozo routinely in the US, as also occurs here in Australia and I think New Zealand. ( for lymphedema diagnosis & checking but also increasing to expanded use in hospitals due to the capabilities of Sozo in renal and for sarcopenia assessment also)

Expand

yes Aqua... well done and I agree with all that ... hopefully people will digest the information and start to have some knowledge and understanding of exactly what they ( PD ) have and where they are up to ..

next 4C I'm keenly interested in sales of course.. revenue.. plus number of patient tests done.. might get close to 50,000 this quarter after Omicron hospital "closures" Jan and Feb.. and .. can they crack over 1,000 approvals in case assistance program this qtr and still at 99% approval rate .. ?? less that 5 weeks to wait ..

IPD Price at posting: 5.8¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

IMA

Issues emerging as Australian companies tackle critical minerals challenge

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

There are more pages in this discussion • 10 more messages in this thread...

First 86 Last

Add IPD (ASX) to my watchlist

(20min delay)
Last 6.0¢		Change -0.001(0.83%)		Mkt cap ! $120.3M

Open	High	Low	Value	Volume
6.0¢	6.0¢	5.9¢	$15.73K	262.9K

Buyers (Bids)

No.	Vol.	Price($)
1	169322	5.9¢

Sellers (Offers)

Price($)	Vol.	No.
6.1¢	124525	1

View Market Depth

No.	Vol.	Price($)
1	104527	0.058
1	412294	0.057
4	226157	0.056
6	372523	0.055
1	1000000	0.054

Price($)	Vol.	No.
0.061	124525	1
0.062	100000	1
0.063	213404	1
0.064	150000	2
0.065	5529	1

Last trade - 15.59pm 11/10/2024 (20 minute delay)

IPD (ASX) Chart

Ann: Appendix 4C & Quarterly Activities Report, page-86

Defence MOU for propulsion systems pushes Aurora Lab shares higher

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Issues emerging as Australian companies tackle critical minerals challenge

Cauldron Energy reports "excellent" uranium assays in latest drill run

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Appendix 4C & Quarterly Activities Report, page-86

Top Stories

Defence MOU for propulsion systems pushes Aurora Lab shares higher

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Issues emerging as Australian companies tackle critical minerals challenge

Cauldron Energy reports "excellent" uranium assays in latest drill run

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News